News (continued)

Creative BioMart, a biotech company that has always been focusing on developing high quality protein products and efficient protein manufacturing techniques, provides services on enzymatic assays to assist scientists focused on enzyme and protein research. The vast majority of catalytic biological processes are accomplished by enzymes that provide multiple functions in living organisms. They are essential for metabolic processes, cell signaling and regulation, and can produce movement and active transport of molecules. Enzymatic reactions can specifically convert substrate molecules into chemically modified products. These modifications include proteolytic or glycolytic degradation, chemical modifications such as phosphorylation, acylation, glycosylation or oxidative and reductive processes. Dysregulation of enzyme activity can lead to disease states. As a result, enzymes are considered attractive targets for pharmacological intervention in drug therapy. Enzyme activity

CD Genomics, established in 2004, is aiming at providing the research community with high-quality Next Generation Sequencing products and services. These days, the product manager of CD Genomics announces that the company has recently optimized DNA library preparation kits, which can meet the most challenging research processes. “High-quality nucleic acid purification and library preparation are critical steps in next-generation sequencing (NGS). Our NGS Reagents are complete sets of optimized reagents that are ideal to convert a small amount of DNA / RNA input into indexed libraries for NGS on Illumina platform. Besides, we offer library prep Kits applicable for a variety of NGS applications including whole-genome sequencing (WGS-seq), RNA sequencing (RNA-seq), whole-genome bisulfite sequencing (WGBS), single-cell transcriptome and whole-genome sequencing (scRNA-seq and scWGS-seq), etc, to cater to the customer`s need.” commented vice president of CD Genomics. DNA

New NIRQuest+ spectrometers detect weaker levels of NIR light Ocean Insight, the applied spectral knowledge company, announces the new NIRQuest+ family of NIR spectrometers. NIRQuest+ spectrometers have an enhanced optical bench design for high-sensitivity performance, allowing for low limits of detection at NIR wavelengths from 900-2500. Three versions (900-1700 nm, 900-2200 nm and 900-2500 nm) are available. NIRQuest+ has great thermal stability and can be used in the lab or on the line, such as on a conveyor belt or in a sample stream, as its higher sensitivity allows users to capture the necessary spectra over shorter integration times. Typical applications include detection of moisture content in fruits and grains; identification of plastics for recycling and materials for industry; and monitoring of ingredients in pharmaceutical processes. NIRQuest+ also can measure very small changes in absorbed signal, which are typical of harmonic overtones in the NIR. Its higher sensitivity enables better measurement accuracy, particularly

ZURICH-Schlieren, Switzerland, Sept. 9, 2020 /PRNewswire/ -- Topadur pharma AG, a clinical stage biopharmaceutical start-up company developing new dual-mode of action drugs that target the cGMP-enzyme regulation system, today announces that it has implemented CDD Vault. The company`s results from drug discovery research programs were successfully digitalized and implemented. CDD Vault is a hosted software platform that manages chemistry and biology data whilst enabling seamless collaboration. CDD Vault is developed by Collaborative Drug Discovery, Inc., a software company headquartered in San Francisco. TOPADUR`s pipeline consists of innovative drug candidates for the treatment of ageing-related diseases. CDD Vault is used as an essential component of the drug development process. It allows Topadur to store, manage and analyze chemical and biological data in a secure way and at the same time share the research information with partners and collaborators. Additionally,

The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial, and companies are teaming up to tackle the growing challenge. But managing collaborative drug discovery data is tough, requiring many small biotechs to rethink how they share and manage their data for antimicrobial development. Andrej Trauner, Project Manager at Swiss biotech BioVersys explains how his company leverages cutting-edge informatics systems to speed up antimicrobial research. See link to full article on Labiotech.

As good as new he Acquity uplc system eliminates significant time and cost per sample from your analytical process while improving the quality of your results. By outperforming traditional or optimized HPLC, this technology allows chromatographers to work at higher efficiencies with a much wider range of linear velocities, flow rates, and backpressures. UPLC Technology, which has been adopted successfully in laboratories around the world for the most demanding separations, is highly robust, dependable, and reproducible. What differentiates the holistic design of Acquity uplc systems is Waters’ patented sub-2-μm hybrid particle chemistry, which offers significant benefits over today`s HPLC systems equipped with standard 5-μm particle chemistries. The Acquity uplc system, used on its own or paired with Waters optical and MS detection technologies, provides unique end-to-end solutions for all industries and applications, including: ADME screening, food safety, bioanalysis,